Home  »  Trendy Stocks   »  Has Progenity (PROG) Stock Risen Pre-Market Sessio...

Has Progenity (PROG) Stock Risen Pre-Market Session For A Reason?

At last check in pre-market trading, Progenity Inc. (PROG) shares were trading at $3.77, an increase of 11.54%. Last session, PROG stock closed at $3.38, increasing 14.19% or $0.42. PROG stock fluctuated between $2.97 and $3.48 throughout the day. In total, 139.66 million shares of PROG stock were exchanged, greater than the company’s 50-day daily volume of 64.87 million and greater than its Year-to-date volume of 16.8 million.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


During the past year, PROG stock has fallen -57.27%, and during the last week, it has risen 13.04%. A total of 7.30% has been gained by the PROG stock over the last six months, and a total of 39.67% over the last three months. This year, the stock has returned -36.35%. PROG stock rises following its debt reduction efforts.

What efforts has PROG made?

Progenity is a biotechnology organization improving in the fields of ladies’ wellbeing, gastrointestinal wellbeing, and oral biotherapeutics. PROG applies a multi-omics approach, joining genomics, epigenomics, proteomics, and metabolomics to its atomic testing items and to the advancement of a set-up of investigational ingestible gadgets intended to give exact analytic examining and medication conveyance arrangements.

PROG’s vision is to change medical services to turn out to be more exact and individual by further developing findings of infection and working on quiet results through limited therapy with designated treatments.

Progenity today declared that it has gone into privately negotiated agreements with specific non-associated holders of its current 7.25% convertible senior notes due 2025 (the “Notes”). PROG haggled to trade a total of $20,175,000 principal amount of Notes for a total of around 8,513,850 shares of its common stock.

The quantity of common stock shares for regard of the interest make-entire arrangements of the agreement includes the Notes issued. The trade exchanges are relied upon by PROG to close approximately October 26, 2021, dependent upon standard closing conditions. PROG won’t get any money continues from the trade exchanges.

The decrease in the debt accomplished by this trade exchange addresses around 38% of PROG’s non-associated obligation. Following the end of the trade exchanges, roughly $137,125,000 in total principal amount of Notes will stay remarkable, with terms unaltered, of which $103,500,000 is held by an associated holder, Athyrium Capital Management, LP.

What else PROG committed further?

Progenity (PROG) likewise consented to give a total of around 427,804 shares of common stock as “Waiver Shares” to specific financial backers in thought for a waiver of specific authoritative lock-up arrangements to which PROG concurred regarding earlier contributions of its protections. PROG won’t get any money continues from the issuance of the waiver shares.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam